NCT00976937 / 2008-007334-22: 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years |
|
|
| Completed | 3 | 319 | US, Canada, Europe, RoW | Lixisenatide (AVE0010), Lixisenatide Placebo, Pen auto-injector, OptiClik®, Sitagliptin, Januvia®, Sitagliptin Placebo, Metformin | Sanofi | Type 2 Diabetes Mellitus | 03/11 | 03/11 | | |
